Produktname:trideuteriomethyl N-[(E)-(1,4-dioxidoquinoxaline-1,4-diium-2-yl)methylideneamino]carbamate
IUPAC Name:3-[(E)-({[(²H₃)methoxycarbonyl]amino}imino)methyl]quinoxaline-1,4-diium-1,4-bis(olate)
- CAS:1185240-06-5
- Molekulare Formel:C11H10N4O4
- Reinheit:95%+
- Katalognummer:CM1010181
- Molekulargewicht:265.24
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:1185240-06-5
- Molekulare Formel:C11H10N4O4
- Schmelzpunkt:-
- SMILES-Code:[2H]C([2H])([2H])OC(=O)N\N=C\C1=C[N+]([O-])=C2C=CC=CC2=[N+]1[O-]
- Dichte:
- Katalognummer:CM1010181
- Molekulargewicht:265.24
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Quinoxalines
- Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.